Skip to content

Occupational Respiratory Allergies and Gene-environment Interactions

Occupational Respiratory Allergies and Gene-environment Interactions

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02879838
Acronym
ARPEIGE
Enrollment
400
Registered
2016-08-26
Start date
2016-09-30
Completion date
2020-09-30
Last updated
2016-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Work Related Asthma

Brief summary

The purpose is to compare clinical, functional, professional and socio-economical characteristics of patients with occupational asthma and work aggravated asthma. Secondary purposes are: * to evaluate diagnostic value of new non-invasive techniques such as exhaled nitric oxide and cytology of induced expectoration; * to estimate medical-social becoming of diagnosed work-related asthma after one year; * to establish a biobank of blood samples of individuals with work related asthma for measurement of cytokines and search for genetic polymorphisms associated with asthma.

Detailed description

Participants with work related asthma or suspected work related asthma will obtain a precise diagnosis concerning severity and control of respiratory disorder and also the possible effect of professional environment on the disorder. Their medical care and medico-legal care, in case of recognition of occupational disease, could be ameliorated. In general, this study will allow the harmonization of diagnostic care and medical, medico-professional and medico-legal management of cases of work related asthma in specialized hospitals.

Interventions

OTHERBlood sample

Biobank. Analysis of cytokines and DNA polymorphisms

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- Patient consulting for suspected work-related asthma in one of hospitals participating to the study

Exclusion criteria

* Patient refusing to participate * Pregnant or breastfeeding women * Individual in life-threatening emergency * Hospitalized patient * Patient in a health or social institution * Person deprived of liberty * Person with total occupational disability * Retired person * Person diagnosed as non-asthmatic * Asthmatic person already enrolled in a clinical trial of bio-therapy to treat asthma

Design outcomes

Primary

MeasureTime frameDescription
Classification of suspected work-related asthma in occupational asthma, work aggravated asthma, non-work-related asthmaInclusionInterpretation of diagnostic algorithm of study

Secondary

MeasureTime frameDescription
Cytology of induced expectorationInclusionBronchial inflammation marker
Nonspecific bronchial hyperreactivity evaluated with metacholine bronchial challenge test and/or isocapnic hyperventilation testInclusion
Nitric oxide levelInclusionBronchial inflammation marker
Severity of symptomsInclusion
Costs of different types of asthmaInclusion and after 1 yearDirect and induced costs
Control of asthma symptoms evaluated with Asthma Control test and peak exploratory flowInclusion

Countries

France

Contacts

Primary ContactChristophe Paris
c.paris@chru-nancy.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026